Synthesis and antimicrobial activity of a carbocyclic puromycin analog. 6-Dimethylamino-9-(R(2R-hydroxy-3R-(p-methoxyphenyl-L alanylamino))-cyclopentyl)purine.
D000818:Animals; D001412:Bacillus subtilis / Q000187:drug effects; D003517:Cyclopentanes / Q000138:chemical synthesis / Q000494:pharmacology; D004926:Escherichia coli / Q000187:drug effects; D007259:Infrared Rays; D007711:Klebsiella pneumoniae / Q000187:drug effects; D009682:Magnetic Resonance Spectroscopy; D013058:Mass Spectrometry; D008826:Microbial Sensitivity Tests; D009404:Nephrotic Syndrome / Q000139:chemically induced; D011691:Puromycin / Q000138:chemical synthesis* / Q000494:pharmacology; D051381:Rats; D013057:Spectrum Analysis; D013210:Staphylococcus / Q000187:drug effects; D013237:Stereoisomerism; D013329:Structure-Activity Relationship; D014466:Ultraviolet Rays
D003517:Cyclopentanes; D011691:Puromycin